======= PPP6R1 =======
== Gene Information ==
* **Official Symbol**: PPP6R1
* **Official Name**: protein phosphatase 6 regulatory subunit 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=22870|22870]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UPN7|Q9UPN7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PPP6R1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PPP6R1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610875|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. Involved in the PP6- mediated dephosphorylation of NFKBIE opposing its degradation in response to TNF-alpha. {ECO:0000269|PubMed:16769727}.
|SAPS|
|Rho GTPase binding|
|vesicle targeting, rough ER to cis-Golgi|
|COPII vesicle coating|
|vesicle coating|
|COPII-coated vesicle budding|
|vesicle targeting, to, from or within Golgi|
|Golgi vesicle budding|
|protein phosphatase binding|
|vesicle targeting|
|vesicle budding from membrane|
|regulation of phosphoprotein phosphatase activity|
|regulation of protein dephosphorylation|
|establishment of vesicle localization|
|regulation of phosphatase activity|
|vesicle localization|
|regulation of dephosphorylation|
|endoplasmic reticulum to Golgi vesicle-mediated transport|
|vesicle organization|
|establishment of organelle localization|
|Golgi vesicle transport|
|organelle localization|
|Golgi membrane|
|membrane organization|
|regulation of hydrolase activity|
|intracellular transport|
|protein-containing complex assembly|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|establishment of localization in cell|
|regulation of protein modification process|
|protein-containing complex subunit organization|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-2.1|
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.96|
|[[:results:exp264|Arsenate 40μM R06 exp264]]|-1.9|
|[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-1.9|
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.75|
|[[:results:exp382|Palbociclib 1μM R07 exp382]]|-1.7|
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.7|
|[[:results:exp285|GW501516 25μM R06 exp285]]|2.15|
|[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.19|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.599|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9192
* **Expression level (log2 read counts)**: 7.87
{{:chemogenomics:nalm6 dist.png?nolink |}}